The paper's citation list
No. | The paper's citation list |
|---|
1 | Biopsychosocial impact of keloids on quality of life. 2024;2:13 doi: 10.1016/j.jdrv.2024.08.010 |
2 | Chronic stress as an emerging risk factor for the development and progression of glioma. 2024;137:394 doi: 10.1097/CM9.0000000000002976 |
3 | Mechanisms of asiaticoside in keloid treatment: Insights from a single-cell transcriptomic approach combined with network pharmacological analysis. 2025;127:733 doi: 10.1016/j.aej.2025.04.086 |
4 | Gazing Long into a Clinical and Social Abyss? Treating Hypertrophic Scarring and Keloids. 2021;24:307 doi: 10.1089/rej.2021.0037 |
5 | An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid. 2023;239:818 doi: 10.1159/000532064 |
